Sudden cardiac death - The challenge to cardiology

Fundamental and Clinical Pharmacology

Volumn 24, Issue 5, 2010, Pages 535-537

  Kjeldsen, Keld ^a,b   Atar, Dan ^c   Hallén, Jonas ^c   Vardas, Panos ^d   Zannad, Faiez ^e   Haunsø, Stig ^a,b  

^a University of Copenhagen   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALDOSTERONE ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGE; ALCOHOL CONSUMPTION; ASYSTOLE; AUTONOMIC DYSFUNCTION; AUTOPSY; CARDIOVASCULAR RISK; CHANNELOPATHY; CHOLESTEROL BLOOD LEVEL; CLINICAL EXAMINATION; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIABETES MELLITUS; DISEASE ASSOCIATION; EDITORIAL; EXERCISE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; GENDER; GENETIC SCREENING; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE ISCHEMIA; HEART PROARRHYTHMIA; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERTROPHIC CARDIOMYOPATHY; HYPOKALEMIA; LONG QT SYNDROME; MASS SCREENING; MEDICAL EXAMINATION; MORTALITY; PRIORITY JOURNAL; SMOKING; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME;

CORONARY ARTERY DISEASE; DEATH, SUDDEN, CARDIAC; HEART FAILURE; HUMANS; RISK FACTORS;

EID: 77956946279     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2010.00875_3.x     Document Type: Editorial

References (26)

1. Lopshire J.C., Zipes D. Sudden cardiac death. Better understanding of risks, mechanisms, and treatment. Circulation (2006) 114 1134 1136.
2. Priori S.G., Aliot E., Blomstrom-Lundqvist C. et al. Task force on sudden cardiac death of the European Society of Cardiology. Eur. Heart J. (2001) 22 1374 1450.
3. Leach I.H., Blundell J.W., Rowley J.M., Turner D.R. Acute ischaemic lesions in death due to ischaemic heart disease. An autopsy study of 333 cases of out-of-hospital death. Eur. Heart J. (1995) 16 1181 1185.
4. Adabag A.S., Peterson G., Apple F.S., Titus J., King R., Luepker R.V. Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am. Heart J. (2010) 159 33 39.
5. Priori S.G., Aliot E., Blomstrom-Lundqvist C. et al. Update of the guidelines on sudden cardiac death of the European Society of Cardiology. Eur. Heart J. (2003) 24 13 15.
6. Fox C.S., Evans J.C., Larson M.G., Kannel W.B., Levy D. Temporal trends in coronary heart disease mortality and sudden cardiac death from 1950 to 1999: the Framingham Heart Study. Circulation (2004) 110 522 527.
7. Huikuri H.V., Castellanos A., Myerburg R.J. Sudden death due to cardiac arrhythmias. N. Engl. J. Med. (2001) 345 1473 1482.
8. Wannamethee G., Shaper A.G., Macfarlane P.W., Walker M. Risk factors for sudden cardiac death in middle-aged British men. Circulation (1995) 91 1749 1956.
9. Jouven X., Desnos M., Guerot C., Ducimetiere P. Predicting sudden death in the population: the Paris Prospective Study I. Circulation (1999) 99 1978 1983.
10. Kannel W.B., Gagnon D.R., Cupples L.A. Epidemiology of sudden coronary death: population at risk. Can. J. Cardiol. (1990) 6 439 444.
11. Yusuf S., Peto R., Lewis J., Collins R., Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog. Cardiovasc. Dis. (1985) 27 335 371.
12. Domanski M.J., Exner D.V., Borkowf C.B., Geller N.L., Rosenberg Y., Pfeffer M.A. Effect of angiotensin converting enzyme inhibition on sudden cardiac death in patients following acute myocardial infarction. A meta-analysis of randomized clinical trials. J. Am. Coll. Cardiol. (1999) 33 598 604.
13. Packer D.L., Prutkin J.M., Hellkamp A.S. et al. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial. Circulation (2009) 120 2170 2176.
14. Das M.K., Zipes D.P. Antiarrhythmic and nonantiarrhythmic drugs for sudden cardiac death prevention. J. Cardiovasc. Pharmacol. (2010) 55 438 449.
15. Zipes D.P., Wyse D.G., Friedman P.L. et al. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N. Engl. J. Med. (1997) 337 1576 1583.
16. Rose G. Strategy of prevention: lessons from cardiovascular disease. Br. Med. J. (Clin. Res. Ed.) (1981) 282 1847 1851.
17. Nissen S.E. Tim Russert and sudden cardiac death after myocardial infarction. Curr. Cardiol. Rep. (2008) 10 343 344.
18. Ackerman M.J., Clapham D.E. Ion channels - basic science and clinical disease. N. Engl. J. Med. (1997) 336 1575 1586.
19. Christiansen M., Tønder N., Larsen L.A. et al. Mutations in the HERG K-channel: a novel link between long QT-syndrome and sudden infant death syndrome. Am. J. Cardiol. 2005) 95 433 434.
20. Havndrup O., Bundgaard H., Andersen P.S. et al. Outcome of clinical versus genetic family screening in hypertrophic cardiomyopathy with focus on cardiac beta-myosin gene mutations. Cardiovasc. Res. (2003) 57 298 301.
21. Clausen T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam. Clin. Pharmacol. (2010) 24 595 605.
22. Paltiel O., Salakhov E., Ronen I., Berg D., Israeli A. Management of severe hypokalemia in hospitalized patients: a study of quality of care based on computerized databases. Arch. Intern. Med. (2001) 161 1089 1095.
23. Nordrehaug J.E., Johannessen K.A., von der Lippe G. Serum potassium concentration as a risk factor of ventricular arrhythmias early in acute myocardial infarction. Circulation (1985) 71 645 649.
24. Etheridge S.P., Compton S.J., Tristani-Firouzi M., Mason J.W. A new oral therapy for long QT syndrome: long-term oral potassium improves repolarization in patients with HERG mutations. J. Am. Coll. Cardiol. (2003) 42 1777 1782.
25. MacDonald J.E., Struthers A.D. What is the optimal serum potassium level in cardiovascular patients? J. Am. Coll. Cardiol. (2004) 43 155 161.
26. Ekundayo O.J., Adamopoulos C., Ahmed M.I. et al. Oral potassium supplement use and outcomes in chronic heart failure: a propensity-matched study. Int. J. Cardiol. (2010) 141 167 174.